Form 8-K - Current report:
SEC Accession No. 0001493152-24-052248
Filing Date
2024-12-27
Accepted
2024-12-27 16:05:20
Documents
15
Period of Report
2024-12-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43355
2 ex99-1.htm EX-99.1 24901
  Complete submission text file 0001493152-24-052248.txt   298229

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bfrg-20241227.xsd EX-101.SCH 3718
4 XBRL DEFINITION FILE bfrg-20241227_def.xml EX-101.DEF 29945
5 XBRL LABEL FILE bfrg-20241227_lab.xml EX-101.LAB 36511
6 XBRL PRESENTATION FILE bfrg-20241227_pre.xml EX-101.PRE 26968
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5647
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 241585764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)